Skip to main content

Table 1 Questionnaires at assessment (T0), baseline (T1), and 3-month follow-up (T2)

From: Understanding and restoring dopaminergic function in fibromyalgia patients using a mindfulness-based psychological intervention: a [18F]-DOPA PET study. Study protocol for the FIBRODOPA study—a randomized controlled trial

Variables

T0

T1

T2

T3

 

Sociodemographic and medical variables

Demographics: for example, age, marital, status, education

x

    

Medical history: for example, duration of FM, medication, treatment

x

    

Lifestyle and health behavior: smoking history, alcohol consumption, exercise

x

    

Psychometric data

M.I.N.I International Neuropsychiatric Interview

x

    

Beck Depression Inventory (BDI, [6])

 

x

x

x

 

State-Trait Anxiety Inventory (STAI, [59])

x

x

x

  

Profile of Mood States, POMS

 

x

x

x

 

Quality of Life, WHOQOL [62]

 

x

x

x

 

Fibromyalgia Questionnaire-Revised (FIQ-R) [9]

 

x

x

x

 

Sleep quality, medical outcomes study sleep scale MOS (Stewart, 1988)

  

x

x

x

Five Facet Mindfulness Questionnaire [3]

 

x

x

x

 

Pain Coping Questionnaire [12]

 

x

x

x

 

Cognitive Emotion Regulation questionnaire (CERQ) [41]

 

x

x

x

 

Savoring Beliefs Inventory [13]

 

x

x

x

 

Temporal Experience of Pleasure Scale ([22])

 

x

x

x

 

Edinburgh Handedness Inventory

x

    

Pain-related outcomes

Brief Pain Inventory (BPI, [15])

 

x

x

x

 

Verbal Rating Scale for current Pain Intensity from SF-36 [70]

 

x

x

x

 

Pain Disability Index [20]

 

x

x

x